Journal of Clinical Endocrinology & Metabolism, Vol 79, 240-247, Copyright © 1994 by Endocrine Society

ARTICLES

A comparison of 13 different immunometric assay kits for gonadotropins: implications for clinical investigation

AE Taylor, RH Khoury and WF Crowley Jr
National Center for Infertility Research, Massachusetts General Hospital, Boston 02114.

To determine whether the new immunometric (sandwich) assays for gonadotropins achieve the alleged improvements over RIAs, we compared 13 commercial kits for LH and FSH with our established and validated polyclonal RIAs. Although the kits claimed detection limits as low as 0.05 IU/L, when sensitivity was tested with a uniform hormone standard (the Second International Reference Preparation of human menopausal gonadotropin urinary standard) and the requirement that the limit must be determined from a detectable standard point rather than the variance around zero, only 4 kits surpassed the detectability achieved by the existing LH and FSH RIAs. Seven of the 10 LH kits tested displayed greater than 10% cross-reactivity with either the alpha- or LH beta- subunit. The relationship between the kit standard and the Second International Reference Preparation of human menopausal gonadotropin uniform standard in each kit was nonlinear, so that attempts to compare results between assays with simple multiplication factors are inaccurate. Only 2 assays were designed to eliminate a hook effect. The following conclusions were reached. 1) Most available gonadotropin immunometric assays do not yet offer features not already available in existing validated polyclonal research assays. 2) Conversion of data from one assay to another is not straightforward. 3) Many of the manufacturers' claims do not appear justified. 4) Determination of the detection limit and other immunometric assay characteristics requires standardization of criteria. We propose the following minimum criteria for validating gonadotropin immunometric assays: 1) a uniform definition of the detection limit based on the lowest distinguishable standard concentration, 2) determination of the standard concentration at which a hook occurs, 3) determination of cross-reactivity to subunits as well as intact gonadotropins, and 4) establishment of an adequate normative data base.

This article has been cited by other articles:

				E. A. M. R. Resende, B. H. J. Lara, J. D. Reis, B. P. Ferreira, G. A. Pereira, and M. F. Borges Assessment of Basal and Gonadotropin-Releasing Hormone-Stimulated Gonadotropins by Immunochemiluminometric and Immunofluorometric Assays in Normal Children J. Clin. Endocrinol. Metab., April 1, 2007; 92(4): 1424 - 1429. [Abstract] [Full Text] [PDF]

				E. A. Nalefski, C. M. D'Antoni, E. P. Ferrell, J. A. Lloyd, H. Qiu, J. L. Harris, and D. H. Whitney Single-molecule detection for femtomolar quantification of proteins in heterogeneous immunoassays. Clin. Chem., November 1, 2006; 52(11): 2172 - 2175. [Full Text] [PDF]

				C. K. Welt, J. L. Chan, J. Bullen, R. Murphy, P. Smith, A. M. DePaoli, A. Karalis, and C. S. Mantzoros Recombinant Human Leptin in Women with Hypothalamic Amenorrhea N. Engl. J. Med., September 2, 2004; 351(10): 987 - 997. [Abstract] [Full Text] [PDF]

				J. M. Adams, A. E. Taylor, W. F. Crowley Jr., and J. E. Hall Polycystic Ovarian Morphology with Regular Ovulatory Cycles: Insights into the Pathophysiology of Polycystic Ovarian Syndrome J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4343 - 4350. [Abstract] [Full Text] [PDF]

				C. K. Welt, P. C. Smith, and A. E. Taylor Evidence of Early Ovarian Aging in Fragile X Premutation Carriers J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4569 - 4574. [Abstract] [Full Text] [PDF]

				C. K. Welt, Y. L. Pagan, P. C. Smith, K. B. Rado, and J. E. Hall Control of Follicle-Stimulating Hormone by Estradiol and the Inhibins: Critical Role of Estradiol at the Hypothalamus during the Luteal-Follicular Transition J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1766 - 1771. [Abstract] [Full Text] [PDF]

				C. K. Welt, A. E. Taylor, K. A. Martin, and J. E. Hall Serum Inhibin B in Polycystic Ovary Syndrome: Regulation by Insulin and Luteinizing Hormone J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5559 - 5565. [Abstract] [Full Text] [PDF]

				L. C. Layman, A. L. A. Porto, J. Xie, L. A. C. R. da Motta, L. D. C. da Motta, W. Weiser, and P. M. Sluss FSH{beta} Gene Mutations in a Female with Partial Breast Development and a Male Sibling with Normal Puberty and Azoospermia J. Clin. Endocrinol. Metab., August 1, 2002; 87(8): 3702 - 3707. [Abstract] [Full Text] [PDF]

				S. Gill, J. L. Sharpless, K. Rado, and J. E. Hall Evidence That GnRH Decreases with Gonadal Steroid Feedback but Increases with Age in Postmenopausal Women J. Clin. Endocrinol. Metab., May 1, 2002; 87(5): 2290 - 2296. [Abstract] [Full Text] [PDF]

				S. Gill, A. E. Taylor, K. A. Martin, C. K. Welt, J. M. Adams, and J. E. Hall Specific Factors Predict the Response to Pulsatile Gonadotropin-Releasing Hormone Therapy in Polycystic Ovarian Syndrome J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2428 - 2436. [Abstract] [Full Text] [PDF]

				A. Olivares, M. Cardenas, C. Timossi, T. Zarinan, V. Diaz-Sanchez, and A. Ulloa-Aguirre Reactivity of different LH and FSH standards and preparations in the World Health Organization matched reagents for enzyme-linked immunoassays of gonadotrophins Hum. Reprod., November 1, 2000; 15(11): 2285 - 2291. [Abstract] [Full Text] [PDF]

				A. L. Schneyer, T. Fujiwara, J. Fox, C. K. Welt, J. Adams, G. M. Messerlian, and A. E. Taylor Dynamic Changes in the Intrafollicular Inhibin/Activin/Follistatin Axis during Human Follicular Development: Relationship to Circulating Hormone Concentrations J. Clin. Endocrinol. Metab., September 1, 2000; 85(9): 3319 - 3330. [Abstract] [Full Text]

				M. P. Rose, R. E. Gaines Das, and A. H. Balen Definition and Measurement of Follicle Stimulating Hormone Endocr. Rev., February 1, 2000; 21(1): 5 - 22. [Abstract] [Full Text]

				C. K. Welt, J. M. Adams, P. M. Sluss, and J. E. Hall Inhibin A and Inhibin B Responses to Gonadotropin Withdrawal Depends on Stage of Follicle Development J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 2163 - 2169. [Abstract] [Full Text]

				A. E. Taylor, B. McCourt, K. A. Martin, E. J. Anderson, J. M. Adams, D. Schoenfeld, and J. E. Hall Determinants of Abnormal Gonadotropin Secretion in Clinically Defined Women with Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., July 1, 1997; 82(7): 2248 - 2256. [Abstract] [Full Text] [PDF]

				S.-B. Hu, L. Johnson, P. C. Roche, and H. T. Keutmann A Functional Determinant in Human Luteinizing Hormone and Chorionic Gonadotropin: Differential Effect of Mutations about {beta}-GLN-54 Endocrinology, April 1, 1997; 138(4): 1627 - 1633. [Abstract] [Full Text] [PDF]